AGREEMENT AND PLAN OF MERGER DATED AS OF JUNE 25, 2024 BY AND AMONG INSUD PHARMA, S.L., EXELTIS PROJECT, INC. AND AGILE THERAPEUTICS, INC.Merger Agreement • June 26th, 2024 • Agile Therapeutics Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of June 25, 2024, among INSUD PHARMA, S.L., a company existing under the laws of Spain (“Parent”), EXELTIS PROJECT, INC., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and AGILE THERAPEUTICS, INC., a Delaware corporation (the “Company”).
REVOLVING PROMISSORY NOTERevolving Promissory Note • June 26th, 2024 • Agile Therapeutics Inc • Pharmaceutical preparations • New York
FOR VALUE RECEIVED, AGILE THERAPEUTICS, INC., a Delaware corporation (“Borrower”), hereby promises to pay to the order of EXELTIS USA, Inc., a New Jersey corporation (the “Lender”), or its registered assigns, on the Stated Expiry Date (as hereinafter defined) or earlier as hereinafter provided the principal sum of up to EIGHT MILLION DOLLARS ($8,000,000) (the “Commitment Amount”).
ContractIntellectual Property Security Agreement • June 26th, 2024 • Agile Therapeutics Inc • Pharmaceutical preparations • New York
This INTELLECTUAL PROPERTY SECURITY AGREEMENT, dated as of June 25, 2024 (this “Agreement”), is entered into by and among AGILE THERAPEUTICS, INC. (“Grantor”), and EXELTIS USA, INC. (“Lender”).
